sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
·ÇçÞÌåÀ࿹Ñ×Ò©ÒýÆðµÄÂýÐÔήËõÐÍθÑ×Ä£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ïû»¯ÏµÍ³Ä£×Ó > ·ÇçÞÌåÀ࿹Ñ×Ò©ÒýÆðµÄÂýÐÔήËõÐÍθÑ×Ä£×Ó

Ç°ÑÔ

θÑ×(gastritis)ÊÇÖ¸±¬·¢ÔÚθð¤Ä¤²ã£¨ÉÏƤϸ°û¡¢¹ÌÓв㡢ð¤Ä¤¼¡£©µÄÑ×Ö¢¡£°´ÁÙ´²·¢²¡µÄ»º¼±ºÍ²¡³ÌµÄÊÇ·Ç£¬·ÖΪ¼±ÐÔθÑ׺ÍÂýÐÔθÑס£¼±ÐÔθÑ×µÄ×éÖ¯²¡ÀíѧÌØÕ÷ÊÇθð¤Ä¤¹ÌÓвãÒÔÖÐÐÔÁ£Ï¸°ûΪÖ÷µÄÑ×ÐÔϸ°û½þÈóÒÔ¼°ÁíÒ»ÀàÒÔÃÓÀóöѪΪÌØÕ÷µÄ¼±ÐÔθð¤Ä¤²¡±ä¡£ÂýÐÔθÑ×ÊÇ Î¸ð¤Ä¤ËðÉËÓëÐÞ¸´Í¬Ê±±£´æµÄÒ»ÖÖ½»ÌæÀú³Ì£¬°´×éÖ¯²¡Àíѧ¸Ä±ä£¬ÓÖ·ÖΪÂýÐÔdz±íÐÍθÑ׺ÍÂýÐÔήËõÐÍθÑ×£¬Ç°ÕßÒÔð¤Ä¤²ãÁÜ°Íϸ°ûºÍ½¬Ï¸°û½þÈóΪÖ÷£¬ºóÕßÒÔÑ×ÐÔϸ°û½þÈóºÍ¹ÌÓвãÏÙÌåïÔÌ­£¨Î®Ëõ£©²¢°éÓÐϸ°ûÔöÉúΪÌØÕ÷¡£Î¸Ñ××îÖ÷ÒªµÄ²¡ÒòÊÇÓÄÃÅÂݸ˾ú(helicobacter pylori,  Hp)ѬȾ£¬ÆäËû²¡ÒòÉÐÓзÇçÞÌåÀ࿹Ñ×Ò©(non-steroidal anti inflammatory drugs,NSAIDs)µÄʹÓá¢Ê®¶þÖ¸³¦Òº·´Á÷¡¢ÒûʳÒòËØ£¨Èç¸ßΡ¢¸ßÑΡ¢ÒÒ´¼¡¢´Ì¼¤ÐÔʳÎÒÔ¼°Ó¦¼¤µÈ¡£

ÔÚ¶¯ÎïÄ£×ÓµÄÖƱ¸ÉÏ£¬¼±ÐÔθÑ×Ò»Ñùƽ³£ÊýÌì»òÊýÖÜÄÚ·ºÆð£¬ÊýÖָܻ´»òǨÑÓÖÁÂýÐÔθÑ×£»ÂýÐÔθÑ×ÔìÄ£Ðèʱ½Ï³¤£¨Ê®¼¸ÖÜÖÁ¼¸Ê®ÖÜ£©£¬ÓÐʱÔÚÂýÐÔθÑ×»ù´¡ÉÏ·ºÆðÔ˶¯ÆÚ£¨¼±ÐÔÆÚ£©ÌåÏÖ£¬Ñ×Ö¢Ò»Á¬±£´æ£¬Ó㦻¯ÉúµÈ°©Ç°²¡±äΣº¦¡£

2005Ä꣬ŵ±´¶ûÐÄÀíѧ»òҽѧ½±ÅäºÏÊÚÓèÁË°Ä´óÀûÑÇ¿Æѧ¼ÒWarrenºÍMarshall£¬±íÑïËûÃǶԓÓÄÃÅÂݸ˾úÒÔ¼°ËüÔÚθÑ׺ÍÏû»¯ÐÔÀ£Ññ²¡ÖеÄ×÷ÓÔÑо¿µÄÓÅÒìТ˳¡£HpÊÇÒýÆðθÑ×µÄÖ÷Òª²¡Ô­¾ú¡£µ«ÔÚ1984ÄêÒÔÇ°£¬Î§ÈÆ×ÅHp¾¿¾¹ÊÇθÑ×µÄÔµ¹ÊÔ­ÓÉ¡¢ÕÕ¾ÉθÑ×µÄЧ¹û£¨»òÅãͬÎ£¬Ñ§Êõ½ç³Ö²î±ð¿´·¨ÇÒÖ÷ÒªÇãÏòÊÇÒÔΪθÑ×»¼ÕßθÄÚ·¢Ã÷µÄHpÊÇÖÆ×÷±ê±¾Àú³ÌÖб»ÎÛȾµÄЧ¹û¡£MarshallÒÔ×ÔÉí¿Ú·þHpÓÕ·¢Á˼±ÐÔθÑס¢¿¹HpÖÎÁƺóθÑ×ȬÓúµÄÊÔÑéЧ¹û£¬Ã÷È·µØ»Ø¸²ÁË´ËÎÊÌâ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

·ÇçÞÌåÀ࿹Ñ×Ò©(NSAIDs)°üÀ¨Ë®ÑîËáÀàµÄ°¢Ë¾Æ¥ÁÖ¡¢ßÅßáÀàµÄßÅßáÃÀÐÁÒÔ¼°±½ÒÒËáÀàµÄË«ÂÈ·ÒËáºÍ±ûËáÀàµÄ²¼Âå·ÒµÈ¡£ËüÃÇͨ¹ýÒÖÖÆ»·¼ÓÑõø£¬ïÔÌ­Ç°ÏßÏÙËØÌìÉúºÍÉø͸£¬µ¼ÖÂθð¤ÒºÌìÉúïÔÌ­¡¢ð¤Ä¤±£»¤×÷ÓÃÏ÷Èõ£¬NSAIDs»¹±¬·¢·´Ó¦ÐÔÑõ×ÔÓÉ»ù(ROS)£¬ÒýÆðϸ°ûµòÍöµÈ¡£ÏÂÃæÒÔßÅßáÀàΪ´ú±íÏÈÈÝÔìÄ£ÒªÁì¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

Sprague Dawley´óÊó£¬ÐÛÐÔ£¬7ÖÜ190~210g¡£Ôìģǰ½ûʳÖÁÉÙ12Сʱ¡£0.05%ßÅßáÃÀÐÁ(indomethacin)ÌìÌì¹àθһ´Î£¬Ã¿´Î8ml/  kg£¬ÉèÖÃßÅßáÃÀÐÁµ¥¶À¹àθ×é¡¢ßÅßáÃÀÐÁ¹àθ¼Ó0.05%~0.1£¥°±Ë®×ÔÓÉÒûÓÃ×é¼°±ÈÕÕ×é¡£Ôìģʱ¼ä·ÖΪ3¸öÔ¡¢6¸öÔºÍ9¸öÔ¡£Ð§¹ûÅú×¢£ºÎÞÂÛßÅßáÃÀÐÁµ¥¶À¹àθ×éÕÕ¾ÉßÅßáÃÀÐÁ¼Ó°±Ë®×飬¸ÅÂÔ¾ù¿É¼ûθð¤Ä¤É«ÔóÒõ»Þ¡¢µ¯ÐԲ²î±ðˮƽµÄ³äѪ¡¢³öѪð¤ÒºÏ£º±¡¢ÖåôÅƽչ»òÏûÊÅ¡£¾µÏ¼û3¸öÔÂ×鶯ÎïµÄθð¤Ä¤ÓÐÏÔ×ÅÑ×ÐÔϸ°û½þÈó£¬6¸öÔÂ×éÑ×ÐÔϸ°û½þÈóÔ½·¢ÑÏÖØ¡¢Î¸ñ¼¹ÌÓÐÏÙÌåïÔÌ­¡¢ÏÙÌåËùÕ¼ÇÐÃæÃæ»ýµÄ±ÈÀýÏÔ×ÅϽµ¡¢¹ÌÓвã±ä±¡¡¢·ºÆðµä·¶µÄήËõÐԸıä¶øð¤Ä¤¼¡²ãÔöºñ¡£9¸öÔÂ×éµÄ²¡Àí ת±ä³ýÏÙÌåÄÒÑùÀ©ÕÅÖ®Í⣬ÆäËû²¡±ä»ù±¾Óë6¸öÔµIJ¡±äÏàͬ¡£ÔÚ×èÖ¹ÔìÄ£´Ì¼¤ºó5ÖÜ£¬Öݪֲ¡ÀíÌåÏÖÈÔÈ»±£´æ¡£

¡¾Ä£×ÓÌص㡿£º

0.05£¥ßÅßáÃÀÐÁ£¬ÎÞÂÛµ¥¶À´Ì¼¤ÕÕ¾ÉÓë0.1£¥°±Ë®ÊÊÓã¬3¸öÔ¿ɷºÆðθÑ×£¬6¡«9¸öÔ¿ɷºÆðÏÔ×ŵÄήËõÐÍθÑ×£¬ÔìÄ£ÀÖ³ÉÂÊ100%£¬Ä£×Ó²¡±äµä·¶£¬ÎȹÌÐԺã¬Á®¼ÛÇáÓ¯¡£

¡¾Ä£×ÓµÄÆÀ¹ÀºÍÓ¦Óá¿£º

¹ØÓÚÁÙ´²ÆÀ¼ÛNSAIDsÓÃÒ©µÄÇå¾²ÐÔ¼°¸±×÷ÓᢹØÓÚÑо¿ÂýÐÔήËõÐÍθÑ×ת¹é¼°¸ÉÔ¤ÖÎÁƵȾùÓвο¼¼ÛÖµ¡£

 

²Î¿¼ÎÄÏ×£º

1.ÎĹúÈÝ£¬ÓàÀö÷£¬µË½­£¬µÈ£®³ÂÏ㶰׶½ºÄÒ¶ÔʵÑéÐÔ¼±ÐÔθÑ×µÄ×÷ÓùóÖÝÒ½Ò©£¬2003,27 (3): 203-204

2.ÁõÀÚ£¬ÀîÇÙ»ª£¬ÅËÖ¾»ª£¬µÈ£®ÁªÕýµ±Ö´óÊóÂýÐÔήËõÐÔθÑ×Ä£×ӵĽ¨É裮ÖйúÈ«¿Æҽѧ£¬2010, 13(11C):3769- 3771

3.榽¡Ãô£¬Îâ¼Ó¹ú£¬²ÜÙ»£¬µÈ£®ÊóÂýÐÔήËõÐÔθÑ×Ä£× ½¨Éè¼°ÖÂήËõÒòËØ̽ÌÖ£®ÖлªÏû»¯ÔÓÖ¾£¬2001,21 (2):75-78

4.ÕÅÈٹ⣬¶Î¹ã²Å£¬·¶ÇåÌ㬵ȣ®ÓÄÃÅÂݸ˾úѬȾµÄÀ¥Ã÷СÊóÄ£×ӵĽ¨ÉèÖлªÒ½Ñ§ÔÓÖ¾£¬2006,86 (12):857-859

5.ÕÅÃô£¬ÀîÇ¿£¬¿×¹Åæ«£®Èý¾Åθ̩¿ÅÁ£ÖÎÁÆʵÑéÐÔ´óÊó¼±ÐÔθÑ×µÄÒ©ÀíÑо¿£®ÏÖ´úÏû»¯¼°½éÈëÕïÁÆÔÓÖ¾£¬2000, 5(4):28-32

6.ÕÅάɭ£¬ÕÅÓÀºê£¬Ðí´ºÐÓ£¬µÈ£®C57BL/6СÊóÓÄÃÅÂݸ˾úѬȾθÑ×Ä£×ӵĸ´ÖÆ£®¹óÖÝÒ½Ò©£¬2013, 37 (2): 105-109

7.¹ù¸Õ£¬ÍõÒ㳬£¬×ÞÈ«Ã÷£¬µÈ£®ÓÄÃÅÂݸ˾úºã¾ÃѬȾÃɹÅɳÊóÄ£×ӵĽ¨É裮ÖлªÎ¢ÉúÎïѧºÍÃâÒßѧÔÓÖ¾£¬2001, 21 (6):683-684

8.÷ÁÖ賦²¡Ñ§Ñо¿µÄÒ»´ÎÍ»ÆÆÒ»2005Äêŵ±´¶ûÐÄÀíѧ»òҽѧ½±ÏÈÈÝ£®ÐÄÀí¿ÆѧϣÍû£¬2006,37(2):187-192

9.Goodwin CS, Armstrong JA, Marshall BJ. Campylobacte.r pyloridis, gastritis, and peptic ulceration. J Clin Pathol, 1986, 39 (4):353-365

10. Kayabali M, Hazar H, Gi.irsoy MA, et al. Free oxygen radicals in restraint -induced stress gastritis in the rat.Surg Today, 1994, 24 (6):530-533

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ïû»¯ÏµÍ³Ä£×Ó > ·ÇçÞÌåÀ࿹Ñ×Ò©ÒýÆðµÄÂýÐÔήËõÐÍθÑ×Ä£×Ó
·ÇçÞÌåÀ࿹Ñ×Ò©ÒýÆðµÄÂýÐÔήËõÐÍθÑ×Ä£×Ó

Ç°ÑÔ

θÑ×(gastritis)ÊÇÖ¸±¬·¢ÔÚθð¤Ä¤²ã£¨ÉÏƤϸ°û¡¢¹ÌÓв㡢ð¤Ä¤¼¡£©µÄÑ×Ö¢¡£°´ÁÙ´²·¢²¡µÄ»º¼±ºÍ²¡³ÌµÄÊÇ·Ç£¬·ÖΪ¼±ÐÔθÑ׺ÍÂýÐÔθÑס£¼±ÐÔθÑ×µÄ×éÖ¯²¡ÀíѧÌØÕ÷ÊÇθð¤Ä¤¹ÌÓвãÒÔÖÐÐÔÁ£Ï¸°ûΪÖ÷µÄÑ×ÐÔϸ°û½þÈóÒÔ¼°ÁíÒ»ÀàÒÔÃÓÀóöѪΪÌØÕ÷µÄ¼±ÐÔθð¤Ä¤²¡±ä¡£ÂýÐÔθÑ×ÊÇ Î¸ð¤Ä¤ËðÉËÓëÐÞ¸´Í¬Ê±±£´æµÄÒ»ÖÖ½»ÌæÀú³Ì£¬°´×éÖ¯²¡Àíѧ¸Ä±ä£¬ÓÖ·ÖΪÂýÐÔdz±íÐÍθÑ׺ÍÂýÐÔήËõÐÍθÑ×£¬Ç°ÕßÒÔð¤Ä¤²ãÁÜ°Íϸ°ûºÍ½¬Ï¸°û½þÈóΪÖ÷£¬ºóÕßÒÔÑ×ÐÔϸ°û½þÈóºÍ¹ÌÓвãÏÙÌåïÔÌ­£¨Î®Ëõ£©²¢°éÓÐϸ°ûÔöÉúΪÌØÕ÷¡£Î¸Ñ××îÖ÷ÒªµÄ²¡ÒòÊÇÓÄÃÅÂݸ˾ú(helicobacter pylori,  Hp)ѬȾ£¬ÆäËû²¡ÒòÉÐÓзÇçÞÌåÀ࿹Ñ×Ò©(non-steroidal anti inflammatory drugs,NSAIDs)µÄʹÓá¢Ê®¶þÖ¸³¦Òº·´Á÷¡¢ÒûʳÒòËØ£¨Èç¸ßΡ¢¸ßÑΡ¢ÒÒ´¼¡¢´Ì¼¤ÐÔʳÎÒÔ¼°Ó¦¼¤µÈ¡£

ÔÚ¶¯ÎïÄ£×ÓµÄÖƱ¸ÉÏ£¬¼±ÐÔθÑ×Ò»Ñùƽ³£ÊýÌì»òÊýÖÜÄÚ·ºÆð£¬ÊýÖָܻ´»òǨÑÓÖÁÂýÐÔθÑ×£»ÂýÐÔθÑ×ÔìÄ£Ðèʱ½Ï³¤£¨Ê®¼¸ÖÜÖÁ¼¸Ê®ÖÜ£©£¬ÓÐʱÔÚÂýÐÔθÑ×»ù´¡ÉÏ·ºÆðÔ˶¯ÆÚ£¨¼±ÐÔÆÚ£©ÌåÏÖ£¬Ñ×Ö¢Ò»Á¬±£´æ£¬Ó㦻¯ÉúµÈ°©Ç°²¡±äΣº¦¡£

2005Ä꣬ŵ±´¶ûÐÄÀíѧ»òҽѧ½±ÅäºÏÊÚÓèÁË°Ä´óÀûÑÇ¿Æѧ¼ÒWarrenºÍMarshall£¬±íÑïËûÃǶԓÓÄÃÅÂݸ˾úÒÔ¼°ËüÔÚθÑ׺ÍÏû»¯ÐÔÀ£Ññ²¡ÖеÄ×÷ÓÔÑо¿µÄÓÅÒìТ˳¡£HpÊÇÒýÆðθÑ×µÄÖ÷Òª²¡Ô­¾ú¡£µ«ÔÚ1984ÄêÒÔÇ°£¬Î§ÈÆ×ÅHp¾¿¾¹ÊÇθÑ×µÄÔµ¹ÊÔ­ÓÉ¡¢ÕÕ¾ÉθÑ×µÄЧ¹û£¨»òÅãͬÎ£¬Ñ§Êõ½ç³Ö²î±ð¿´·¨ÇÒÖ÷ÒªÇãÏòÊÇÒÔΪθÑ×»¼ÕßθÄÚ·¢Ã÷µÄHpÊÇÖÆ×÷±ê±¾Àú³ÌÖб»ÎÛȾµÄЧ¹û¡£MarshallÒÔ×ÔÉí¿Ú·þHpÓÕ·¢Á˼±ÐÔθÑס¢¿¹HpÖÎÁƺóθÑ×ȬÓúµÄÊÔÑéЧ¹û£¬Ã÷È·µØ»Ø¸²ÁË´ËÎÊÌâ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

·ÇçÞÌåÀ࿹Ñ×Ò©(NSAIDs)°üÀ¨Ë®ÑîËáÀàµÄ°¢Ë¾Æ¥ÁÖ¡¢ßÅßáÀàµÄßÅßáÃÀÐÁÒÔ¼°±½ÒÒËáÀàµÄË«ÂÈ·ÒËáºÍ±ûËáÀàµÄ²¼Âå·ÒµÈ¡£ËüÃÇͨ¹ýÒÖÖÆ»·¼ÓÑõø£¬ïÔÌ­Ç°ÏßÏÙËØÌìÉúºÍÉø͸£¬µ¼ÖÂθð¤ÒºÌìÉúïÔÌ­¡¢ð¤Ä¤±£»¤×÷ÓÃÏ÷Èõ£¬NSAIDs»¹±¬·¢·´Ó¦ÐÔÑõ×ÔÓÉ»ù(ROS)£¬ÒýÆðϸ°ûµòÍöµÈ¡£ÏÂÃæÒÔßÅßáÀàΪ´ú±íÏÈÈÝÔìÄ£ÒªÁì¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

Sprague Dawley´óÊó£¬ÐÛÐÔ£¬7ÖÜ190~210g¡£Ôìģǰ½ûʳÖÁÉÙ12Сʱ¡£0.05%ßÅßáÃÀÐÁ(indomethacin)ÌìÌì¹àθһ´Î£¬Ã¿´Î8ml/  kg£¬ÉèÖÃßÅßáÃÀÐÁµ¥¶À¹àθ×é¡¢ßÅßáÃÀÐÁ¹àθ¼Ó0.05%~0.1£¥°±Ë®×ÔÓÉÒûÓÃ×é¼°±ÈÕÕ×é¡£Ôìģʱ¼ä·ÖΪ3¸öÔ¡¢6¸öÔºÍ9¸öÔ¡£Ð§¹ûÅú×¢£ºÎÞÂÛßÅßáÃÀÐÁµ¥¶À¹àθ×éÕÕ¾ÉßÅßáÃÀÐÁ¼Ó°±Ë®×飬¸ÅÂÔ¾ù¿É¼ûθð¤Ä¤É«ÔóÒõ»Þ¡¢µ¯ÐԲ²î±ðˮƽµÄ³äѪ¡¢³öѪð¤ÒºÏ£º±¡¢ÖåôÅƽչ»òÏûÊÅ¡£¾µÏ¼û3¸öÔÂ×鶯ÎïµÄθð¤Ä¤ÓÐÏÔ×ÅÑ×ÐÔϸ°û½þÈó£¬6¸öÔÂ×éÑ×ÐÔϸ°û½þÈóÔ½·¢ÑÏÖØ¡¢Î¸ñ¼¹ÌÓÐÏÙÌåïÔÌ­¡¢ÏÙÌåËùÕ¼ÇÐÃæÃæ»ýµÄ±ÈÀýÏÔ×ÅϽµ¡¢¹ÌÓвã±ä±¡¡¢·ºÆðµä·¶µÄήËõÐԸıä¶øð¤Ä¤¼¡²ãÔöºñ¡£9¸öÔÂ×éµÄ²¡Àí ת±ä³ýÏÙÌåÄÒÑùÀ©ÕÅÖ®Í⣬ÆäËû²¡±ä»ù±¾Óë6¸öÔµIJ¡±äÏàͬ¡£ÔÚ×èÖ¹ÔìÄ£´Ì¼¤ºó5ÖÜ£¬Öݪֲ¡ÀíÌåÏÖÈÔÈ»±£´æ¡£

¡¾Ä£×ÓÌص㡿£º

0.05£¥ßÅßáÃÀÐÁ£¬ÎÞÂÛµ¥¶À´Ì¼¤ÕÕ¾ÉÓë0.1£¥°±Ë®ÊÊÓã¬3¸öÔ¿ɷºÆðθÑ×£¬6¡«9¸öÔ¿ɷºÆðÏÔ×ŵÄήËõÐÍθÑ×£¬ÔìÄ£ÀÖ³ÉÂÊ100%£¬Ä£×Ó²¡±äµä·¶£¬ÎȹÌÐԺã¬Á®¼ÛÇáÓ¯¡£

¡¾Ä£×ÓµÄÆÀ¹ÀºÍÓ¦Óá¿£º

¹ØÓÚÁÙ´²ÆÀ¼ÛNSAIDsÓÃÒ©µÄÇå¾²ÐÔ¼°¸±×÷ÓᢹØÓÚÑо¿ÂýÐÔήËõÐÍθÑ×ת¹é¼°¸ÉÔ¤ÖÎÁƵȾùÓвο¼¼ÛÖµ¡£

 

²Î¿¼ÎÄÏ×£º

1.ÎĹúÈÝ£¬ÓàÀö÷£¬µË½­£¬µÈ£®³ÂÏ㶰׶½ºÄÒ¶ÔʵÑéÐÔ¼±ÐÔθÑ×µÄ×÷ÓùóÖÝÒ½Ò©£¬2003,27 (3): 203-204

2.ÁõÀÚ£¬ÀîÇÙ»ª£¬ÅËÖ¾»ª£¬µÈ£®ÁªÕýµ±Ö´óÊóÂýÐÔήËõÐÔθÑ×Ä£×ӵĽ¨É裮ÖйúÈ«¿Æҽѧ£¬2010, 13(11C):3769- 3771

3.榽¡Ãô£¬Îâ¼Ó¹ú£¬²ÜÙ»£¬µÈ£®ÊóÂýÐÔήËõÐÔθÑ×Ä£× ½¨Éè¼°ÖÂήËõÒòËØ̽ÌÖ£®ÖлªÏû»¯ÔÓÖ¾£¬2001,21 (2):75-78

4.ÕÅÈٹ⣬¶Î¹ã²Å£¬·¶ÇåÌ㬵ȣ®ÓÄÃÅÂݸ˾úѬȾµÄÀ¥Ã÷СÊóÄ£×ӵĽ¨ÉèÖлªÒ½Ñ§ÔÓÖ¾£¬2006,86 (12):857-859

5.ÕÅÃô£¬ÀîÇ¿£¬¿×¹Åæ«£®Èý¾Åθ̩¿ÅÁ£ÖÎÁÆʵÑéÐÔ´óÊó¼±ÐÔθÑ×µÄÒ©ÀíÑо¿£®ÏÖ´úÏû»¯¼°½éÈëÕïÁÆÔÓÖ¾£¬2000, 5(4):28-32

6.ÕÅάɭ£¬ÕÅÓÀºê£¬Ðí´ºÐÓ£¬µÈ£®C57BL/6СÊóÓÄÃÅÂݸ˾úѬȾθÑ×Ä£×ӵĸ´ÖÆ£®¹óÖÝÒ½Ò©£¬2013, 37 (2): 105-109

7.¹ù¸Õ£¬ÍõÒ㳬£¬×ÞÈ«Ã÷£¬µÈ£®ÓÄÃÅÂݸ˾úºã¾ÃѬȾÃɹÅɳÊóÄ£×ӵĽ¨É裮ÖлªÎ¢ÉúÎïѧºÍÃâÒßѧÔÓÖ¾£¬2001, 21 (6):683-684

8.÷ÁÖ賦²¡Ñ§Ñо¿µÄÒ»´ÎÍ»ÆÆÒ»2005Äêŵ±´¶ûÐÄÀíѧ»òҽѧ½±ÏÈÈÝ£®ÐÄÀí¿ÆѧϣÍû£¬2006,37(2):187-192

9.Goodwin CS, Armstrong JA, Marshall BJ. Campylobacte.r pyloridis, gastritis, and peptic ulceration. J Clin Pathol, 1986, 39 (4):353-365

10. Kayabali M, Hazar H, Gi.irsoy MA, et al. Free oxygen radicals in restraint -induced stress gastritis in the rat.Surg Today, 1994, 24 (6):530-533

¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿